Summit X, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History

Summit X, LLC

$437 Million
Q4 2024

A detailed history of Summit X, LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Summit X, LLC holds 2,306 shares of XBI stock, worth $210,791. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,306

Holding current value

$210,791

% of portfolio

0.05%

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 07, 2025	BUY	$89.81 - $104.0 $207,101 - $239,824	2,306 New	2,306 $207,000

Others Institutions Holding XBI

# of Institutions

912

Shares Held

102M

Call Options Held

27.7M

Put Options Held

39M

Citigroup Inc

11.2M
Shares

$1.02 Billion
0.62% of portfolio
Morgan Stanley New York, NY

10.2M
Shares

$930 Million
0.07% of portfolio
Goldman Sachs Group Inc New York, NY

9.56M
Shares

$873 Million
0.14% of portfolio
Bank Of America Corp Charlotte, NC

8.52M
Shares

$779 Million
0.07% of portfolio
Jpmorgan Chase & CO New York, NY

8.01M
Shares

$732 Million
0.06% of portfolio

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit X, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit X, LLC with notifications on news.

Account